Found: 19
Select item for more details and to access through your institution.
Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma.
- Published in:
- Applied Health Economics & Health Policy, 2019, v. 17, n. 5, p. 655, doi. 10.1007/s40258-019-00482-7
- By:
- Publication type:
- Article
Biomarkers of immunotherapy response in breast cancer beyond PD-L1.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 1, p. 39, doi. 10.1007/s10549-021-06421-2
- By:
- Publication type:
- Article
Successful Switch to Vemurafenib Plus Cobimetinib After Dabrafenib Plus Trametinib Toxicity in BRAF<sup>V600E</sup>-Mutant Metastatic Non-Small-Cell Lung Cancer.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Frequency and spectrum of PIK3CA somatic mutations in breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00216-w
- By:
- Publication type:
- Article
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 12/3/2021, p. 1, doi. 10.1038/s41523-021-00218-8
- By:
- Publication type:
- Article
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-020-00208-2
- By:
- Publication type:
- Article
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67126-2
- By:
- Publication type:
- Article
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67126-2
- By:
- Publication type:
- Article
Cytology Smears: An Enhanced Alternative Method for Colorectal Cancer pN Stage—A Multicentre Study.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6072, doi. 10.3390/cancers14246072
- By:
- Publication type:
- Article
ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1902, doi. 10.3390/cancers12071902
- By:
- Publication type:
- Article
Gene expression profiles of breast cancer metastasis according to organ site.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 1, p. 69, doi. 10.1002/1878-0261.13021
- By:
- Publication type:
- Article
Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.710596
- By:
- Publication type:
- Article
Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00625-7
- By:
- Publication type:
- Article
Author Correction: Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 1, p. 69, doi. 10.1093/jnci/djad179
- By:
- Publication type:
- Article
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 3, p. 332, doi. 10.1093/jnci/djac227
- By:
- Publication type:
- Article
Tumor Cellularity and Infiltrating Lymphocytes as a Survival Surrogate in HER2-Positive Breast Cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-019-14111-3
- By:
- Publication type:
- Article